Henry F. Blissenbach

Henry F. Blissenbach

Nessuna posizione attualmente

82 anni
Distribution Services
Health Technology
Health Services

Profilo

Henry F.
Blissenbach
, serves as a Director, President and Chief Executive Officer for BioScrip Inc. Dr. Blissenbach was named to this position upon the consummation of the merger between MIM Corporation and Chronimed, Inc. effective March 2005.
Dr. Blissenbach previously served as Chairman and Chief Executive Officer of Chronimed, Inc. He was appointed Chairman of the Board of Directors and Chief Executive Officer of Chronimed on July 1, 2000.
Dr. Blissenbach was named President and Chief Operating Officer of Chronimed in May 1997.
He became a director of Chronimed in September 1995.
From 1992 to 1997, he served as President of Diversified Pharmaceutical Services, Inc., a UnitedHealthcare subsidiary until 1994 and afterwards a subsidiary of SmithKline Beecham Corp.
Diversified Pharmaceutical Services, Inc. was a pharmacy benefit management firm.
Dr. Blissenbach also serves as a director of Ligand Pharmaceuticals Inc., a publicly held biopharmaceutical development company, and Opportunity Partners, Inc., a nonprofit company.

Precedenti posizioni note di Henry F. Blissenbach

SocietàPosizioneFine
Presidente 09/08/2004
Presidente -
LIGAND PHARMACEUTICALS INCORPORATED Direttore/Membro del Consiglio -
Vedi nel dettaglio l'esperienza di Henry F. Blissenbach

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Henry F. Blissenbach

Società collegate

Società quotate in Borsa1
LIGAND PHARMACEUTICALS INCORPORATED

Health Technology

Aziende private2

Distribution Services

Health Services

  1. Borsa valori
  2. Insiders
  3. Henry F. Blissenbach